FDA approves new blood test for Alzheimer’s disease
Everything below was taken directly out of the reporting and the official record — quotations word for word, legislation straight from Congress.gov. The Record wrote none of it and takes no position on any of it.
From the Article
The opening of the original reporting, reproduced word for word and bounded on purpose — the outlet that wrote it should get the full read.
Reported by The Hill. The paragraphs below are the opening of that article, reproduced word for word — not a summary, and not the whole piece.
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease , marking the fourth time such a blood test has been approved in less than two years.
Roche announced Sunday that the FDA had granted approval to its Elecsys Phospho-Tau blood test for diagnosing Alzheimer’s disease. It’s the fourth such test to be granted FDA approval after the first was given the green light in May 2025 .
Developed in collaboration with Eli Lilly, the test is intended for people 55 years and older with “signs, symptoms, or complaints of cognitive decline.” The test may help physicians identify patients who should be considered for further evaluation earlier, according to Roche.
Continue reading at The Hill →What Both Sides Are Saying
Quoted word for word from this story, grouped by who said them. Nothing here was written or summarized by The Record.
Republican & Conservative Voices
No statements on file from this side yet.
Democratic & Progressive Voices
No statements on file from this side yet.